Abstract
Bronchoconstriction and degenerative lesions of the bronchial epithelium were observed microscopically 1 min after the i.v. injection of 100 ng/kg of platelet-activating factor (PAF-acether) to the anaesthesized guinea-pig. Constricted arterioles containing marginated polymorphonuclear neutrophils and platelet aggregates were seen, as well as alveolar capillaries obstructed by thrombi formed by partially or totally degranulated platelets. Three minutes after the injection of PAF-acether, platelet diapedesis to the alveolar septa and lumen was clearly observed. Bronchoconstriction was still present at 3 min, but subsided after 60 min, whereas oedema of the submucosa persisted accompanied by an infiltration of eosinophils and neutrophils. The infusion of prostacyclin prevented the formation of platelet aggregates and platelet diapedesis due to PAF-acether, but the morphological evidence of bronchial constriction was not modified. Aspirin failed completely to modify the effects of PAF-acether. Our results show that PAF-acether causes early formation and deposition of platelet aggregates, accompanied by the margination of polymorphonuclear neutrophil leucocytes in pulmonary vessels of the guinea-pig. Since bronchoconstriction persisted when platelet aggregation was inhibited with prostacyclin, aggregation by itself would not account for this effect. Early platelet diapedesis in the vicinity of bronchial smooth muscle corroborates previous evidence that platelets contain and release bronchoconstrictor substances, which operate by cyclo-oxygenase-independent mechanisms and are possibly involved with the physiopathology of lung inflammation during immediate hypersensitivity.
Full text
PDF![345](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/864079ea9e12/brjexppathol00087-0087.png)
![346](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/c409786cef81/brjexppathol00087-0088.png)
![347](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/8d639da56a34/brjexppathol00087-0089.png)
![348](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/afd4e50384ff/brjexppathol00087-0090.png)
![349](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/7eaa0973875b/brjexppathol00087-0091.png)
![350](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/4578c5de93c8/brjexppathol00087-0092.png)
![351](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/4c3deab38ec5/brjexppathol00087-0093.png)
![352](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/a3c8d14e2cbc/brjexppathol00087-0094.png)
![353](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/ea9368790bc0/brjexppathol00087-0095.png)
![354](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/3d2f5c842f56/brjexppathol00087-0096.png)
![355](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb97/2041063/602e0ae47647/brjexppathol00087-0097.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Basran G. S., Page C. P., Paul W., Morley J. Platelet-activating factor: a possible mediator of the dual response to allergen? Clin Allergy. 1984 Jan;14(1):75–79. doi: 10.1111/j.1365-2222.1984.tb02193.x. [DOI] [PubMed] [Google Scholar]
- Camussi G., Tetta C., Bussolino F., Caligaris Cappio F., Coda R., Masera C., Segoloni G. Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation. Int Arch Allergy Appl Immunol. 1981;64(1):25–41. doi: 10.1159/000232671. [DOI] [PubMed] [Google Scholar]
- Chignard M., Le Couedic J. P., Tence M., Vargaftig B. B., Benveniste J. The role of platelet-activating factor in platelet aggregation. Nature. 1979 Jun 28;279(5716):799–800. doi: 10.1038/279799a0. [DOI] [PubMed] [Google Scholar]
- Knauer K. A., Lichtenstein L. M., Adkinson N. F., Jr, Fish J. E. Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med. 1981 Jun 4;304(23):1404–1407. doi: 10.1056/NEJM198106043042307. [DOI] [PubMed] [Google Scholar]
- Lefort J., Rotilio D., Vargaftig B. B. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Br J Pharmacol. 1984 Jul;82(3):565–575. doi: 10.1111/j.1476-5381.1984.tb10795.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lefort J., Vargaftig B. B. Role of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid. Br J Pharmacol. 1978 May;63(1):35–42. doi: 10.1111/j.1476-5381.1978.tb07771.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vargaftig B. B., Lefort J., Chignard M., Benveniste J. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol. 1980 Jul 25;65(2-3):185–192. doi: 10.1016/0014-2999(80)90391-x. [DOI] [PubMed] [Google Scholar]